Excretory Urography A Comparison of Iopamidol and Meglumine Diatrizoate
William Moreau Thompson
Abstract
William Moreau Thompson
Abstract
This article reviews the physiologic and clinical aspects of intravenous unographic contrast agents and discusses adverse reactions. The ionic agent meglumine diatrizoate and the nonionic agent iopamidol are compared. The results of some clinical trials and experimental studies have shown that iopamidol is a better contrast agent for excretory urography than ionic agents. More extensive clinical trials are needed to verify these results.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This article reviews the physiologic and clinical aspects of intravenous unographic contrast agents and discusses adverse reactions. The ionic agent meglumine diatrizoate and the nonionic agent iopamidol are compared. The results of some clinical trials and experimental studies have shown that iopamidol is a better contrast agent for excretory urography than ionic agents. More extensive clinical trials are needed to verify these results.
Key concepts: Iopamidol, Diatrizoate Meglumine, Meglumine, Diatrizoate, Pyelogram, Metrizamide, Medicine, Clinical trial